Ignite Creation Date:
2024-05-06 @ 2:43 PM
Last Modification Date:
2024-10-26 @ 1:36 PM
Study NCT ID:
NCT04408118
Status:
COMPLETED
Last Update Posted:
2024-06-04
First Post:
2020-05-20
Brief Title:
First Line Atezolizumab Paclitaxel and Bevacizumab Avastin in mTNBC
Sponsor:
MedSIR
Organization:
MedSIR
Organization Data
Organization:
MedSIR
Class:
OTHER
Study ID:
MedOPP150
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedSIR
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |